Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEyal Ben David - CEOJiahong Li - Co-CEO and CFOLior Dayan - ChairmanConference Call ParticipantsJin Xin Ding - AnalystJingheng He - AnalystNate Zhou - Equity Research AnalystNone - AnalystJingheng HeLadies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joini ...